Preprint
Antibody Characterization Report for PPP2R5D
Zenodo
11/10/2023
DOI: 10.5281/zenodo.10108247
Abstract
A peer-reviewed antibody characterization article corresponding to this Zenodo preprint is openly available at F1000Research: https://doi.org/10.12688/f1000research.145146.2
This report presents a guide to selecting high-quality commercial antibodies against Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PPP2R5D) by Western blot, immunoprecipitation, immunofluorescence and immunohistochemistry, using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls.
This study was funded in part by the Simons Foundation Autism Research Initiative (SFARI), an organization that funds innovative research to enhance the understanding, diagnosis and treatment of autism spectrum disorders.
Details
- Title: Subtitle
- Antibody Characterization Report for PPP2R5D
- Creators
- Riham Ayoubi - Montreal Neurological Institute and HospitalCharles Alende - Montreal Neurological Institute and HospitalMaryam Fotouhi - Montreal Neurological Institute and HospitalChunling Chen - University of IowaKathleen Southern - Montreal Neurological Institute and HospitalStefan Strack - University of IowaVincent Francis - Montreal Neurological Institute and HospitalPeter McPherson - Montreal Neurological Institute and HospitalCarl Laflamme - Montreal Neurological Institute and Hospital
- Resource Type
- Preprint
- DOI
- 10.5281/zenodo.10108247
- Publisher
- Zenodo
- Number of pages
- 20 pages
- Language
- English
- Date posted
- 11/10/2023
- Date updated
- 06/15/2026
- Academic Unit
- Pathology; Iowa Neuroscience Institute; Fraternal Order of Eagles Diabetes Research Center; Neuroscience and Pharmacology
- Record Identifier
- 9985245475102771
Metrics
1 Record Views